These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33020154)

  • 1. Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.
    Lanoiselée J; Zufferey PJ; Hodin S; Tamisier N; Gergelé L; Palao JC; Campisi S; Molliex S; Morel J; Delavenne X; Ollier E
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis during and after cardiopulmonary bypass.
    Rimmler C; Lanckohr C; Mittrup M; Welp H; Würthwein G; Horn D; Fobker M; Ellger B; Hempel G
    Br J Clin Pharmacol; 2021 Mar; 87(3):1486-1498. PubMed ID: 32959896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
    Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
    Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.
    Rimmler C; Lanckohr C; Akamp C; Horn D; Fobker M; Wiebe K; Redwan B; Ellger B; Koeck R; Hempel G
    Br J Clin Pharmacol; 2019 Dec; 85(12):2864-2877. PubMed ID: 31487057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.
    Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A
    Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.
    Bertholee D; ter Horst PG; Hijmering ML; Spanjersberg AJ; Hospes W; Wilffert B
    Int J Clin Pharm; 2013 Oct; 35(5):798-804. PubMed ID: 23794078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.
    Pojar M; Mandak J; Malakova J; Jokesova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):139-45. PubMed ID: 18795089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass.
    Urbánek K; Šantavý P; Zuščich O; Kubíčková V; Michaličková D; Slanař O; Šíma M
    J Chemother; 2023 Nov; 35(7):614-622. PubMed ID: 36715134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic model of cefazolin in total hip arthroplasty.
    Lanoiselée J; Chaux R; Hodin S; Bourayou S; Gibert A; Philippot R; Molliex S; Zufferey PJ; Delavenne X; Ollier E
    Sci Rep; 2021 Oct; 11(1):19763. PubMed ID: 34611213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
    Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.
    Kirby A; Asín-Prieto E; Burns FA; Ewin D; Fatania K; Kailavasan M; Nisar S; Pericleous A; Trocóniz IF; Burke D
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):357-363. PubMed ID: 30519893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.
    Gertler R; Gruber M; Grassin-Delyle S; Urien S; Martin K; Tassani-Prell P; Braun S; Burg S; Wiesner G
    Br J Clin Pharmacol; 2017 Aug; 83(8):1745-1757. PubMed ID: 28245519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
    Grassin-Delyle S; Tremey B; Abe E; Fischler M; Alvarez JC; Devillier P; Urien S
    Br J Anaesth; 2013 Dec; 111(6):916-24. PubMed ID: 23880099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.